Sign In
Buy NVTA
$0.0190
+0 (+0%)
At Close: May 13, 2024
Invitae (NVTA) Reports Q2 Loss, Tops Revenue Estimates
09:21pm, Tuesday, 03'rd Aug 2021
Invitae (NVTA) delivered earnings and revenue surprises of -30.77% and 6.19%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Invitae to Announce Second Quarter 2021 Financial Results on Tuesday, August 3, 2021
07:30am, Tuesday, 20'th Jul 2021
SAN FRANCISCO, July 20, 2021 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that it will report its second quarter 2021 financial results on Tue
3 Little Known AI Stocks for the Future
01:00pm, Sunday, 18'th Jul 2021
With the global release of 5G connectivity, machine learning has become more of a secular trend than ever before.
Why Bionano Genomics, Invitae, and Opko Health Stocks Sank This Week
07:01am, Friday, 16'th Jul 2021
The market's pessimism about these diagnostics stocks appeared unrelated to company-specific news.
Tech Bubble 2.0 + Inflation Tsunami: How to Play Them Now
01:53pm, Thursday, 15'th Jul 2021
Morgan Stanley warns investors 15% correction coming as market overvalued like dot-com days.
Where Will ARK Genomic Revolution ETF Be in 5 Years?
06:12am, Saturday, 10'th Jul 2021
Cathie Wood's genomics ETF is making big bets on the "Genomic Age."
Invitae appoints technology and medtech veteran Roxi Wen as chief financial officer
07:30am, Friday, 11'th Jun 2021
SAN FRANCISCO, June 11, 2021 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced the appointment of Roxi Wen as its chief financial officer, effective June 21, 20
Why Invitae Was Down 17.5% in May
03:46pm, Tuesday, 08'th Jun 2021
The genetic testing company's growth isn't the kind that impresses Wall Street.
5 Healthcare Stocks to Buy for Their Game-Changing Potential
11:37am, Tuesday, 08'th Jun 2021
These healthcare stocks are at the forefront of huge trends, including precision medicine and advances in diagnosis technologies. The post 5 Healthcare Stocks to Buy for Their Game-Changing Potential
Invitae Corporation (NVTA) CEO Sean George Presents at William Blair 41st Annual Growth Stock Conference (Transcript)
08:08pm, Saturday, 05'th Jun 2021
Invitae Corporation (NVTA) CEO Sean George Presents at William Blair 41st Annual Growth Stock Conference (Transcript)
This Biotech Just Made History. Will Its Stock Follow?
12:55pm, Friday, 04'th Jun 2021
Twenty years after the human genome was sequenced, a new wave of discovery has begun.
Invitae: Dilution Is Stunting Shareholders
12:55am, Wednesday, 02'nd Jun 2021
Invitae: Dilution Is Stunting Shareholders
Can Invitae Be the Winner-Take-Most in Genetic Testing?
06:10am, Saturday, 29'th May 2021
Just like in poker, in some markets, the winner can take the whole pot. Can Invitae take home all the chips?
Germline genetic testing can benefit all cancer patients as a routine practice in cancer care
07:30am, Tuesday, 25'th May 2021
SAN FRANCISCO, May 25, 2021 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, is presenting multiple studies in multiple cancer types at the 2021 American Society
EXCLUSIVE: Invitae CEO On Making Genetics Cost-Effective And Accessible
12:35pm, Friday, 21'st May 2021
San Francisco-headquartered Invitae Corp (NYSE: NVTA) defines itself as medical genetics company seeking to bring comprehensive genetic information into mainstream medicine, with the goal of improving
